Possible involvement of phosphatidylinositol 3 kinase in experimental vascular endothelium dysfunction

dc.contributor.guideManjeet Singhen_US
dc.coverage.spatialpharmacyen_US
dc.creator.researcherSharma, Saurabhen_US
dc.date.accessioned2013-05-17T11:06:52Z
dc.date.available2013-05-17T11:06:52Z
dc.date.awardedn.d.en_US
dc.date.completed2012en_US
dc.date.issued2013-05-17
dc.date.registered2007en_US
dc.description.abstractVascular endothelium plays a role in capillary transport of nutrients and drugs and regulates angiogenesis, homeostasis, as well as vascular tone and permeability As a major regulator of local vascular homeostasis, the endothelium maintains the balance between vasodilatation and vasoconstriction, procoagulant and anticoagulant, prothrombotic and antithrombotic mechanisms. Diabetes mellitus causes the activation of aldose reductase, polyol pathway and advanced glycation-end-product formation that collectively affect the phosphorylation status and expression of endothelial nitric oxide synthatase (eNOS) and causes vascular endothelium dysfunction. Elevated homocysteine levels have been associated with increase in LDL oxidation, generation of hydrogen peroxides, superoxide anions that increased oxidative degradation of nitric oxide. Hyperhomocysteinemia has been reported to increase the endogenous competitive inhibitors of eNOS viz- L-N-monomethyl arginine (L-NMMA) and asymmetric dimethyl arginine (ADMA) that may contribute to vascular endothelial dysfunction. Hypercholesterolemia stimulates oxidation of LDL-cholesterol, release of endothelins, and generation of ROS. The increased cholesterol and triglyceride level and decreased protective HDL level, decreases the activity and expression of eNOS and disrupts the integrity of vascular endothelium, due to oxidative stress. Hypertension also stimulates release of endothelins, vasoconstrictor prostanoids, angiotensin II, inflammatory cytokines, xanthine oxidase and, thereby, reduces bioavailability of nitric oxide. Thus, the cellular and molecular mechanisms underlying diabetes mellitus, hyperhomocysteinemia, hypercholestrolemmia and hypertension leads to animbalance of phosphorylation and dephosphorylation status of lipid and protein kinase that cause modulation of vascular endothelial L-arginine/nitric oxide synthetase (eNOS), to produce vascular endothelium dysfunction.en_US
dc.description.noteBibliography p.116-145en_US
dc.format.accompanyingmaterialNoneen_US
dc.format.dimensions-en_US
dc.format.extent145p.en_US
dc.identifier.urihttp://hdl.handle.net/10603/8948
dc.languageEnglishen_US
dc.publisher.institutionDepartment of Pharmacyen_US
dc.publisher.placeKalurthalaen_US
dc.publisher.universityPunjab Technical Universityen_US
dc.relation-en_US
dc.rightsuniversityen_US
dc.source.inflibnetINFLIBNETen_US
dc.subject.keywordpharmacyen_US
dc.subject.keywordvascular endotheliumen_US
dc.subject.keywordEndothelialen_US
dc.subject.keywordEndothelial Phenotypesen_US
dc.titlePossible involvement of phosphatidylinositol 3 kinase in experimental vascular endothelium dysfunctionen_US
dc.title.alternative-en_US
dc.type.degreePh.D.en_US

Files

Original bundle

Now showing 1 - 5 of 17
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
104.73 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_dedication.pdf
Size:
284.44 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_declaration.pdf
Size:
89.84 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_acknowledgement.pdf
Size:
71.15 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_abstract.pdf
Size:
69.42 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: